A. Batchelor, D. Piper, F. De-la-brousse, S. Mcknight, and C. Wolberger, The Structure of GABP/: An ETS Domain- Ankyrin Repeat Heterodimer Bound to DNA, Science, vol.279, issue.5353, pp.1037-1041, 1998.
DOI : 10.1126/science.279.5353.1037

R. Baumgartner, C. Fernandez-catalan, A. Winoto, R. Huber, R. Engh et al., Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a, Structure, vol.6, issue.10, pp.1279-1290, 1998.
DOI : 10.1016/S0969-2126(98)00128-2

M. Classon and E. Harlow, The retinoblastoma tumour suppressor in development and cancer, Nature Reviews Cancer, vol.2, issue.12, pp.910-917, 2002.
DOI : 10.1038/nrc950

N. Fahham, M. Ghahremani, S. Sardari, B. Vaziri, and S. Ostad, Simulation of different truncated p16 forms and in silico study of interaction with Cdk4, Cancer Inform, vol.7, pp.1-11, 2009.

R. Fahraeus and D. Lane, The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts, 1999.

R. Fahraeus, J. Paramio, K. Ball, S. Lain, and D. Lane, Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide from p16CDKN2/INK4A, Current Biology, vol.6, issue.1, pp.84-91, 1996.
DOI : 10.1016/S0960-9822(02)00425-6

S. Frost, D. Simpson, R. Clayton, and W. Farrell, Arrest in the AtT20 Pituitary Tumor Cell Line, Molecular Endocrinology, vol.13, issue.11, pp.1801-1810, 1999.
DOI : 10.1210/mend.13.11.0374

H. Harada, K. Nakagawa, S. Iwata, M. Saito, Y. Kumon et al., Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas, Cancer Res, vol.59, pp.3783-3789, 1999.

J. Herman, A. Merlo, L. Mao, R. Lapidus, J. Issa et al., Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res, vol.55, pp.4525-4530, 1995.

J. Koh, G. Enders, B. Dynlacht, and E. Harlow, Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition, Nature, vol.375, issue.6531, pp.506-510, 1995.
DOI : 10.1038/375506a0

W. Li, J. Fan, D. Hochhauser, D. Banerjee, Z. Zielinski et al., Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines., Proceedings of the National Academy of Sciences, vol.92, issue.22, pp.10436-10440, 1995.
DOI : 10.1073/pnas.92.22.10436

B. Mcconnell, F. Gregory, F. Stott, E. Hara, and G. Peters, Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes, Molecular and Cellular Biology, vol.19, issue.3, pp.1981-1989, 1999.
DOI : 10.1128/MCB.19.3.1981

N. Mcdonald and G. Peters, Ankyrin for clues about the function 0fp16INK4a, Nature Structural Biology, vol.6, issue.2, pp.85-88, 1998.
DOI : 10.1093/hmg/6.12.2061

P. Michaely and V. Bennett, The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats, J Biol Chem, vol.268, pp.22703-22709, 1993.

P. Obexer, J. Hagenbuchner, M. Rupp, C. Salvador, M. Holzner et al., p16INK4A Sensitizes Human Leukemia Cells to FAS- and Glucocorticoid-induced Apoptosis via Induction of BBC3/Puma and Repression of MCL1 and BCL2, Journal of Biological Chemistry, vol.284, issue.45, pp.30933-30940, 2009.
DOI : 10.1074/jbc.M109.051441

S. Ortega, M. Malumbres, and M. Barbacid, Cyclin D-dependent kinases, INK4 inhibitors and cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1602, issue.1, pp.73-87, 2002.
DOI : 10.1016/S0304-419X(02)00037-9

M. Paggi, A. Baldi, F. Bonetto, and A. Giordano, Retinoblastoma protein family in cell cycle and cancer: A review, Journal of Cellular Biochemistry, vol.18, issue.3, pp.418-430, 1996.
DOI : 10.1002/(SICI)1097-4644(199609)62:3<418::AID-JCB12>3.0.CO;2-E

D. Parry and G. Peters, Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma., Molecular and Cellular Biology, vol.16, issue.7, pp.3844-3852, 1996.
DOI : 10.1128/MCB.16.7.3844

N. Pavletich, Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors, Journal of Molecular Biology, vol.287, issue.5, pp.821-828, 1999.
DOI : 10.1006/jmbi.1999.2640

P. Ramirez, D. Gershenson, G. Tortolero-luna, L. Ramondetta, D. Fightmaster et al., Expression of Cell-Cycle Mediators in Ovarian Cancer Cells after Transfection with p16INK4a, p21WAF1/Cip-1, and p53, p21(WAF1/Cip-1), and p53, pp.543-548, 2001.
DOI : 10.1006/gyno.2001.6438

I. Roninson, Tumor cell senescence in cancer treatment, Cancer Res, vol.63, pp.2705-2715, 2003.

A. Russo, L. Tong, J. Lee, P. Jeffrey, and N. Pavletich, Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a, Nature, vol.395, pp.237-243, 1998.

M. Serrano, The Tumor Suppressor Protein p16INK4a, Experimental Cell Research, vol.237, issue.1, pp.7-13, 1997.
DOI : 10.1006/excr.1997.3824

B. Smith-sorensen and E. Hovig, CDKN2A (p16INK4A) somatic and germline mutations, Human Mutation, vol.9, issue.4, pp.294-303, 1996.
DOI : 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9

K. Tang, A. Fersht, and L. Itzhaki, Sequential Unfolding of Ankyrin Repeats in Tumor Suppressor p16, Structure, vol.11, issue.1, pp.67-73, 2003.
DOI : 10.1016/S0969-2126(02)00929-2

K. Tang, B. Guralnick, W. Wang, A. Fersht, and L. Itzhaki, Stability and folding of the tumour suppressor protein p16, Journal of Molecular Biology, vol.285, issue.4, pp.1869-1886, 1999.
DOI : 10.1006/jmbi.1998.2420

O. Villacanas, J. Perez, and J. Rubio-martinez, through Molecular Dynamics Simulations, Journal of Biomolecular Structure and Dynamics, vol.12, issue.3, pp.347-358, 2002.
DOI : 10.1093/bioinformatics/15.4.327

R. Weinberg, The retinoblastoma protein and cell cycle control, Cell, vol.81, issue.3, pp.323-330, 1995.
DOI : 10.1016/0092-8674(95)90385-2

N. Whitaker, T. Bryan, P. Bonnefin, A. Chang, E. Musgrove et al., Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells, Oncogene, vol.11, pp.971-976, 1995.

Q. Xie, Y. Hu, L. Wang, Z. Chen, X. Diao et al., The co-transfection of p16INK4a and p14ARF genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity, Colloids and Surfaces B: Biointerfaces, vol.46, issue.3, pp.188-196, 2005.
DOI : 10.1016/j.colsurfb.2005.10.006

R. Yang, A. Gombart, M. Serrano, and H. Koeffler, Mutational effects on the p16INK4a tumor suppressor protein, Cancer Res, vol.55, pp.2503-2506, 1995.

R. Yang, M. Serrano, J. Slater, E. Leung, and H. Koeffler, Analysis of p16INK4aand Its Interaction with CDK4, Biochemical and Biophysical Research Communications, vol.218, issue.1, pp.254-259, 1996.
DOI : 10.1006/bbrc.1996.0045

W. Yarbrough, R. Buckmire, M. Bessho, and E. Liu, Biologic and Biochemical Analyses of p16INK4a Mutations From Primary Tumors, JNCI Journal of the National Cancer Institute, vol.91, issue.18, pp.1569-1574, 1999.
DOI : 10.1093/jnci/91.18.1569

C. Yuan, J. Li, T. Selby, I. Byeon, and M. Tsai, Tumor suppressor INK4: comparisons of conformational properties between p16INK4A and p18INK4C, Journal of Molecular Biology, vol.294, issue.1, pp.201-211, 1999.
DOI : 10.1006/jmbi.1999.3231

B. Zhang and Z. Peng, A minimum folding unit in the ankyrin repeat protein p16INK4, Journal of Molecular Biology, vol.299, issue.4, pp.1121-1132, 2000.
DOI : 10.1006/jmbi.2000.3803